Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Filings indexed 1,031 across all filing types
Latest filing 2026-05-05 Major Shareholding Noti…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR-Transparency-Notification-EN-20260505.pdf
Major Shareholding Notification
2026-05-05 English
OXUR-Transparency-Notification-NL-20260505.pdf
Major Shareholding Notification
2026-05-05 Dutch
Oxurion - Special report BoD 7-228_exe.pdf
Regulatory Filings
2026-04-30 English
Oxurion - Special report BoD 7-228 (NL)_exe.pdf
Regulatory Filings
2026-04-30 Dutch
Oxurion_Voting_Form_AGM_2026_exe.pdf
Regulatory Filings
2026-04-30 Dutch
Oxurion_Convening notice_AGM_2026_exe.pdf
Regulatory Filings
2026-04-30 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.